These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 28258726)

  • 41. Cortical thinning and its relation to cognition in amyotrophic lateral sclerosis.
    Schuster C; Kasper E; Dyrba M; Machts J; Bittner D; Kaufmann J; Mitchell AJ; Benecke R; Teipel S; Vielhaber S; Prudlo J
    Neurobiol Aging; 2014 Jan; 35(1):240-6. PubMed ID: 23992619
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Frontotemporal degeneration in the patient with amyotrophic lateral sclerosis: helping the caregiver cope.
    Houseman G; Walsh S; Brothers A; Lyter J; Simmons Z; Klapper J
    J Neurosci Nurs; 2013 Apr; 45(2):96-100. PubMed ID: 23422695
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Amyotrophic lateral sclerosis modifies progenitor neural proliferation in adult classic neurogenic brain niches.
    Galán L; Gómez-Pinedo U; Guerrero A; García-Verdugo JM; Matías-Guiu J
    BMC Neurol; 2017 Sep; 17(1):173. PubMed ID: 28874134
    [TBL] [Abstract][Full Text] [Related]  

  • 44. TDP-43 and FUS in amyotrophic lateral sclerosis and frontotemporal dementia.
    Mackenzie IR; Rademakers R; Neumann M
    Lancet Neurol; 2010 Oct; 9(10):995-1007. PubMed ID: 20864052
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Characterization of amyotrophic lateral sclerosis and frontotemporal dementia.
    Lomen-Hoerth C
    Dement Geriatr Cogn Disord; 2004; 17(4):337-41. PubMed ID: 15178949
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Survival in Frontotemporal Dementia Phenotypes: A Meta-Analysis.
    Kansal K; Mareddy M; Sloane KL; Minc AA; Rabins PV; McGready JB; Onyike CU
    Dement Geriatr Cogn Disord; 2016; 41(1-2):109-22. PubMed ID: 26854827
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Characterization of the repeat expansion size in C9orf72 in amyotrophic lateral sclerosis and frontotemporal dementia.
    Dols-Icardo O; García-Redondo A; Rojas-García R; Sánchez-Valle R; Noguera A; Gómez-Tortosa E; Pastor P; Hernández I; Esteban-Pérez J; Suárez-Calvet M; Antón-Aguirre S; Amer G; Ortega-Cubero S; Blesa R; Fortea J; Alcolea D; Capdevila A; Antonell A; Lladó A; Muñoz-Blanco JL; Mora JS; Galán-Dávila L; Rodríguez De Rivera FJ; Lleó A; Clarimón J
    Hum Mol Genet; 2014 Feb; 23(3):749-54. PubMed ID: 24057670
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Neuropsychiatric symptoms and survival in amyotrophic lateral sclerosis: a missing link?
    Mioshi E; Roberts R; Hornberger M
    Neurodegener Dis Manag; 2015; 5(2):89-91. PubMed ID: 25894870
    [No Abstract]   [Full Text] [Related]  

  • 49. The Role of APOE in the Occurrence of Frontotemporal Dementia in Amyotrophic Lateral Sclerosis.
    Chiò A; Brunetti M; Barberis M; Iazzolino B; Montuschi A; Ilardi A; Cammarosano S; Canosa A; Moglia C; Calvo A
    JAMA Neurol; 2016 Apr; 73(4):425-30. PubMed ID: 26903389
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [The amyotrophic lateral sclerosis syndrome--frontal-type dementia].
    Iakhno NN; Shtul'tan DR; Elkin MN; Zakharov VV
    Zh Nevrol Psikhiatr Im S S Korsakova; 1995; 95(1):20-3. PubMed ID: 7778388
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Recent advances in the genetics of amyotrophic lateral sclerosis and frontotemporal dementia: common pathways in neurodegenerative disease.
    Talbot K; Ansorge O
    Hum Mol Genet; 2006 Oct; 15 Spec No 2():R182-7. PubMed ID: 16987882
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [ALS and frontotemporal dementia - case report and review of the literature].
    Nass RD; Meister IG; Haupt WF; Fink GR
    Fortschr Neurol Psychiatr; 2012 Dec; 80(12):711-9. PubMed ID: 23229103
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Co-occurrence of the C9ORF72 expansion and a novel GRN mutation in a family with alternative expression of frontotemporal dementia and amyotrophic lateral sclerosis.
    Testi S; Tamburin S; Zanette G; Fabrizi GM
    J Alzheimers Dis; 2015; 44(1):49-56. PubMed ID: 25182743
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Structural insight into C9orf72 hexanucleotide repeat expansions: Towards new therapeutic targets in FTD-ALS.
    Kumar V; Kashav T; Islam A; Ahmad F; Hassan MI
    Neurochem Int; 2016 Nov; 100():11-20. PubMed ID: 27539655
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Amyotrophic lateral sclerosis and frontotemporal dementia: distinct and overlapping changes in eating behaviour and metabolism.
    Ahmed RM; Irish M; Piguet O; Halliday GM; Ittner LM; Farooqi S; Hodges JR; Kiernan MC
    Lancet Neurol; 2016 Mar; 15(3):332-42. PubMed ID: 26822748
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Screening for the C9ORF72 repeat expansion in a greek frontotemporal dementia cohort.
    Kartanou C; Karadima G; Koutsis G; Breza M; Papageorgiou SG; Paraskevas GP; Kapaki E; Panas M
    Amyotroph Lateral Scler Frontotemporal Degener; 2018 Feb; 19(1-2):152-154. PubMed ID: 29166782
    [TBL] [Abstract][Full Text] [Related]  

  • 57. C9orf72 hexanucleotide repeat expansions as the causative mutation for chromosome 9p21-linked amyotrophic lateral sclerosis and frontotemporal dementia.
    Daoud H; Suhail H; Sabbagh M; Belzil V; Szuto A; Dionne-Laporte A; Khoris J; Camu W; Salachas F; Meininger V; Mathieu J; Strong M; Dion PA; Rouleau GA
    Arch Neurol; 2012 Sep; 69(9):1159-63. PubMed ID: 22964911
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Screening in ALS and FTD patients reveals 3 novel UBQLN2 mutations outside the PXX domain and a pure FTD phenotype.
    Synofzik M; Maetzler W; Grehl T; Prudlo J; Vom Hagen JM; Haack T; Rebassoo P; Munz M; Schöls L; Biskup S
    Neurobiol Aging; 2012 Dec; 33(12):2949.e13-7. PubMed ID: 22892309
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Differences in inflammatory profiles between ALS and FTD.
    Vucic S
    J Neurol Neurosurg Psychiatry; 2019 Jan; 90(1):1. PubMed ID: 30224547
    [No Abstract]   [Full Text] [Related]  

  • 60. Transmissible agent in the amyotrophic form of Creutzfeldt-Jakob disease.
    Connolly JH; Allen IV; Dermott E
    J Neurol Neurosurg Psychiatry; 1988 Nov; 51(11):1459-60. PubMed ID: 3069961
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.